Success Metrics

Completion Rate
0%(0/1)
Active Trials
5(71%)
Terminated
1(14%)

Phase Distribution

Ph phase_1
3
43%
Ph early_phase_1
3
43%

Phase Distribution

6

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
3(50.0%)
Phase 1Safety & dosage
3(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

7

all time

Status Distribution
Active(5)
Terminated(1)
Other(1)

Detailed Status

Recruiting3
Active, not recruiting2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
5
Success Rate
0.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 13 (50.0%)
Phase 13 (50.0%)

Trials by Status

terminated114%
unknown114%
active_not_recruiting229%
recruiting343%

Recent Activity

5 active trials
Showing 5 of 7
active_not_recruitingearly_phase_1

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

NCT03334500
recruitingphase_1

FTT PET/CT in Pancreatic Neuroendocrine Tumors

NCT07114939
active_not_recruitingphase_1

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer

NCT03083288
recruitingphase_1

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

NCT02637934
recruiting

FTT PET/CT in Metastatic Prostate Cancer

NCT05242744
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03334500Early Phase 1

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

Active Not Recruiting
NCT07114939Phase 1

FTT PET/CT in Pancreatic Neuroendocrine Tumors

Recruiting
NCT03083288Phase 1

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer

Active Not Recruiting
NCT02637934Phase 1

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Recruiting
NCT05242744

FTT PET/CT in Metastatic Prostate Cancer

Recruiting
NCT04221061Early Phase 1

18F-FluorThanatrace (PET/CT) in Glioblastoma

Terminated
NCT02469129Early Phase 1

PET Imaging of PARP Activity in Cancer

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7